CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 279 filers reported holding CYTOKINETICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,051,989 | -17.5% | 35,703 | -8.7% | 0.25% | -8.8% |
Q2 2023 | $1,275,247 | -12.5% | 39,112 | -5.6% | 0.27% | -14.9% |
Q1 2023 | $1,457,367 | -27.1% | 41,426 | -5.3% | 0.32% | -28.3% |
Q4 2022 | $1,998,755 | +33.8% | 43,746 | +41.8% | 0.45% | +30.1% |
Q3 2022 | $1,494,000 | +14.7% | 30,849 | -7.0% | 0.34% | +25.9% |
Q2 2022 | $1,303,000 | -1.7% | 33,170 | -7.9% | 0.27% | +37.7% |
Q1 2022 | $1,326,000 | -20.3% | 36,016 | -1.3% | 0.20% | -8.3% |
Q4 2021 | $1,664,000 | – | 36,487 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |